Name | Number of supported studies | Average coverage | |
---|---|---|---|
platelet | 10 studies | 45% ± 11% | |
enterocyte | 7 studies | 31% ± 12% | |
astrocyte | 6 studies | 32% ± 21% | |
oligodendrocyte | 5 studies | 31% ± 15% | |
megakaryocyte | 4 studies | 61% ± 21% | |
GABAergic neuron | 4 studies | 44% ± 18% | |
glutamatergic neuron | 4 studies | 50% ± 18% | |
epithelial cell | 3 studies | 42% ± 33% | |
adipocyte | 3 studies | 22% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 3% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 28% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 691.62 | 2589 / 2642 | 96% | 23.96 | 675 / 705 |
ovary | 83% | 282.42 | 149 / 180 | 89% | 43.42 | 383 / 430 |
skin | 82% | 392.31 | 1490 / 1809 | 68% | 9.12 | 323 / 472 |
intestine | 100% | 2204.04 | 966 / 966 | 51% | 3.95 | 267 / 527 |
pancreas | 100% | 876.58 | 328 / 328 | 49% | 4.51 | 87 / 178 |
kidney | 99% | 522.91 | 88 / 89 | 48% | 4.12 | 430 / 901 |
stomach | 99% | 561.73 | 355 / 359 | 47% | 3.88 | 135 / 286 |
esophagus | 87% | 596.58 | 1260 / 1445 | 41% | 3.41 | 75 / 183 |
bladder | 100% | 627.71 | 21 / 21 | 25% | 1.77 | 125 / 504 |
uterus | 100% | 995.35 | 170 / 170 | 24% | 8.34 | 112 / 459 |
prostate | 100% | 1029.67 | 244 / 245 | 23% | 1.26 | 115 / 502 |
thymus | 99% | 521.39 | 648 / 653 | 23% | 1.32 | 140 / 605 |
breast | 97% | 547.32 | 443 / 459 | 14% | 1.24 | 156 / 1118 |
adrenal gland | 93% | 784.35 | 239 / 258 | 13% | 0.78 | 31 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.61 | 1 / 1 |
spleen | 98% | 493.28 | 236 / 241 | 0% | 0 | 0 / 0 |
muscle | 97% | 861.68 | 781 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 1072.96 | 822 / 861 | 0% | 0 | 0 / 0 |
lung | 78% | 377.15 | 453 / 578 | 17% | 1.26 | 195 / 1155 |
adipose | 91% | 359.84 | 1090 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 86% | 536.77 | 800 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 79% | 380.53 | 1052 / 1335 | 0% | 0 | 0 / 0 |
liver | 51% | 155.35 | 116 / 226 | 9% | 0.51 | 37 / 406 |
eye | 0% | 0 | 0 / 0 | 39% | 2.34 | 31 / 80 |
lymph node | 0% | 0 | 0 / 0 | 31% | 2.58 | 9 / 29 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.59 | 6 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005886 | Cellular component | plasma membrane |
GO_0034237 | Molecular function | protein kinase A regulatory subunit binding |
GO_0005515 | Molecular function | protein binding |
Gene name | C2orf88 |
Protein name | Chromosome 2 open reading frame 88 Small membrane A-kinase anchor protein (Small membrane AKAP) (smAKAP) Small membrane A-kinase anchor protein |
Synonyms | |
Description | FUNCTION: Binds to type I regulatory subunits of protein kinase A (PKA-RI) and may anchor/target them to the plasma membrane. . |
Accessions | ENST00000396974.2 Q9BSF0 C9JS57 ENST00000443551.2 H7BZ15 ENST00000409545.2 ENST00000450357.5 ENST00000340623.4 ENST00000409870.1 |